Early treatment of candidemia in adults: a review

References

• Kao AS, Brandt ME, Pruitt WR, . The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999; 29: 1164–1170.
   PubMed Web of Science ®Google Scholar
• Snydman DR. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 2003; 123: 500S–503S.
   PubMed Web of Science ®Google Scholar
• Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642–2645.
   PubMed Web of Science ®Google Scholar
• Olaechea PM, Palomar M, Leon-Gil C, . Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 2004; 23: 323–330.
   PubMedGoogle Scholar
• Horn DL, Neofytos D, Anaissie EJ, . Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695–1703.
   PubMed Web of Science ®Google Scholar
• Abi-Said D, Anaissie E, Uzun O, . The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122–1128.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Armstrong-James D. Invasive Candida species infection: the importance of adequate empirical antifungal therapy. J Antimicrob Chemother 2007; 60: 459–460.
   PubMed Web of Science ®Google Scholar
• Golan Y, Wolf MP, Pauker SG, Wong JB, Hadley S. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med 2005; 143: 857–869.
   PubMed Web of Science ®Google Scholar
• Kumar A, Roberts D, Wood KE, . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589–1596.
   PubMed Web of Science ®Google Scholar
• Kumar A, Ellis P, Arabi Y, . Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136: 1237–1248.
   PubMed Web of Science ®Google Scholar
• Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49: 3640–3645.
   PubMed Web of Science ®Google Scholar
• Garey KW, Rege M, Pai MP, . Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006; 43: 25–31.
   PubMed Web of Science ®Google Scholar
• Schuster MG, Edwards JE, Jr., Sobel JD, . Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008; 149: 83–90.
   PubMed Web of Science ®Google Scholar
• Menichetti F, Del FA, Martino P, . Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. Clin Infect Dis 1999; 28: 250–255.
   PubMed Web of Science ®Google Scholar
• Pelz RK, Hendrix CW, Swoboda SM, . Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233: 542–548.
   PubMed Web of Science ®Google Scholar
• Marr KA, Seidel K, Slavin MA, . Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000; 96: 2055–2061.
   PubMed Web of Science ®Google Scholar
• van Burik JA, Ratanatharathorn V, Stepan DE, . Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004; 39: 1407–1416.
   PubMed Web of Science ®Google Scholar
• Cruciani M, de LF, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 2005; 31: 1479–1487.
   PubMed Web of Science ®Google Scholar
• Schelenz S. Management of candidiasis in the intensive care unit. J Antimicrob Chemother 2008; 61(Suppl. 1): i31–i34.
   Google Scholar
• Glocker EO, Hennigs A, Nabavi M, . A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009; 361: 1727–1735.
   PubMed Web of Science ®Google Scholar
• Ferwerda B, Ferwerda G, Plantinga TS, . Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009; 361: 1760–1767.
   PubMed Web of Science ®Google Scholar
• Plantinga TS, van d, V, Ferwerda B, . Early stop polymorphism in human DECTIN-1 is associated with increased Candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis 2009; 49: 724–732.
   PubMed Web of Science ®Google Scholar
• Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751–758.
   PubMed Web of Science ®Google Scholar
• Munoz P, Burillo A, Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents 2000; 15: 83–90.
   PubMed Web of Science ®Google Scholar
• Piarroux R, Grenouillet F, Balvay P, . Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004; 32: 2443–2449.
   PubMed Web of Science ®Google Scholar
• Mootien JY, Balvay P, Kuteifan K, . Assessment of corrected colonization index and invasive fungal infection in medical intensive care unit. Presented at: 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 17–20 September 2007; Abstract M-625; Chicago, IL.
   Google Scholar
• Paphitou NI, Ostrosky-Zeichner L, Rex JH. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005; 43: 235–243.
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Sable C, Sobel J, . Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007; 26: 271–276.
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Pappas P, Shoham S. Revalidation and improvement of a clinical prediction rule (CPR) for clinical trials on prophylaxis of invasive candidiasis (IC) in the ICU. Presented at: 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 27–30 September 2006; Abstract M-883; San Francisco, CA.
   Google Scholar
• Faiz S, Neale B, Rios E, . Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit. Eur J Clin Microbiol Infect Dis 2009; 28: 689–692.
   PubMedGoogle Scholar
• Leon C, Ruiz-Santana S, Saavedra P, . Usefulness of the ‘Candida score’ for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009; 37: 1624–1633.
   PubMed Web of Science ®Google Scholar
• Leon C, Ruiz-Santana S, Saavedra P, . A bedside scoring system (‘Candida score’) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34: 730–737.
   PubMed Web of Science ®Google Scholar
• Charles PE, Castro C, Ruiz-Santana S, . Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med 2009; 35: 2146–2150.
   PubMedGoogle Scholar
• Reiss E, Morrison CJ. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev 1993; 6: 311–323.
   PubMed Web of Science ®Google Scholar
• Pizzo PA, Walsh TJ. Fungal infections in the pediatric cancer patient. Semin Oncol 1990; 17: 6–9.
   PubMed Web of Science ®Google Scholar
• Yera H, Sendid B, Francois N, Camus D, Poulain D. Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur J Clin Microbiol Infect Dis 2001; 20: 864–870.
   PubMed Web of Science ®Google Scholar
• Sendid B, Poirot JL, Tabouret M, . Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 2002; 51: 433–442.
   PubMed Web of Science ®Google Scholar
• Ellis M, Al-Ramadi B, Bernsen R, . Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J Med Microbiol 2009; 58: 606–615.
   PubMed Web of Science ®Google Scholar
• Obayashi T, Yoshida M, Mori T, . Plasma (1–>3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17–20.
   PubMed Web of Science ®Google Scholar
• Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 2007; 7: 103.
   PubMed Web of Science ®Google Scholar
• Digby J, Kalbfleisch J, Glenn A, . Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 2003; 10: 882–885.
   PubMedGoogle Scholar
• Ellis M, Al-Ramadi B, Finkelman M, . Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008; 57: 287–295.
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E, . Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199–205.
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Alexander BD, Kett DH, . Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654–659.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005; 43: 5957–5962.
   PubMed Web of Science ®Google Scholar
• Senn L, Robinson JO, Schmidt S, . 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008; 46: 878–885.
   PubMed Web of Science ®Google Scholar
• Kanda H, Kubo K, Hamasaki K, . Influence of various hemodialysis membranes on the plasma (1–>3)-beta-D-glucan level. Kidney Int 2001; 60: 319–323.
   PubMed Web of Science ®Google Scholar
• Nagasawa K, Yano T, Kitabayashi G, . Experimental proof of contamination of blood components by (1-->3)-beta-D-glucan caused by filtration with cellulose filters in the manufacturing process. J Artif Organs 2003; 6: 49–54.
   PubMedGoogle Scholar
• Kimura Y, Nakao A, Tamura H, Tanaka S, Takagi H. Clinical and experimental studies of the limulus test after digestive surgery. Surg Today 1995; 25: 790–794.
   PubMed Web of Science ®Google Scholar
• Usami M, Ohata A, Horiuchi T, . Positive (1–>3)-beta-D-glucan in blood components and release of (1–>3)-beta-D-glucan from depth-type membrane filters for blood processing. Transfusion 2002; 42: 1189–1195.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Hori H, Niiguchi S, Azuma E, Komada Y. False-positive plasma (1–>3)-beta-D-glucan test following immunoglobulin product replacement in an adult bone marrow recipient. Int J Hematol 2004; 80: 97–98.
   PubMed Web of Science ®Google Scholar
• Marty FM, Lowry CM, Lempitski SJ, . Reactivity of (1–>3)-beta-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother 2006; 50: 3450–3453.
   PubMed Web of Science ®Google Scholar
• Takesue Y, Kakehashi M, Ohge H, . Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 2004; 28: 625–630.
   PubMed Web of Science ®Google Scholar